RT @sanoysalvoblog: ⚠️Soluciones de hidroxietil-almidón: recomendación de suspensión de comercialización, por sus conocidos efectos adverso…
⚠️Soluciones de hidroxietil-almidón: recomendación de suspensión de comercialización, por sus conocidos efectos adversos renales Recomienda el PRAC de la @EMA_News. Informa @AEMPSGOB: https://t.co/yYhWYL8ezN Revisión @cochranecollab 2013: https://t.co/Hbq
⚠️Soluciones de hidroxietil-almidón: recomendación de suspensión de comercialización, por sus conocidos efectos adversos renales Recomienda el PRAC de la @EMA_News. Informa @AEMPSGOB: https://t.co/ahn4HJLEwD Revisión @cochranecollab 2013: https://t.co/Ebk
Y que nos decís de los almidones? https://t.co/niIhbypfOd
Updated Cochrane review of HES and renal function just published http://t.co/PjtW3umDkm
Updated Cochrane review of HES and renal function just published http://t.co/PjtW3umDkm
Updated Cochrane review of HES and renal function just published http://t.co/PjtW3umDkm
Updated Cochrane review of HES and renal function just published http://t.co/PjtW3umDkm
Updated Cochrane review of HES and renal function just published http://t.co/PjtW3umDkm
Cochrane Review finds HES products up risk for kidney damage, and a "safe volume" has yet to be determined: http://t.co/xmDJH2GMFS
Cochrane Review finds HES products up risk for kidney damage, and a "safe volume" has yet to be determined: http://t.co/xmDJH2GMFS
Cochrane Review finds HES products up risk for kidney damage, and a "safe volume" has yet to be determined: http://t.co/xmDJH2GMFS
Cochrane Review finds HES products up risk for kidney damage, and a "safe volume" has yet to be determined: http://t.co/xmDJH2GMFS
COCHRANE:"all HES products increase the risk in AKI and RRT in all patient populations" http://t.co/YftQEd4KHF
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.: Hydroxyethyl starch (HES)... http://t.co/VHJtBghpsr
Updated review just published - Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function http://t.co/cAxlK9mMoQ